Harvoni

Gilead to launch generic versions of its hepatitis drugs

Gilead to launch generic versions of its hepatitis drugs

FOSTER CITY — Gilead Sciences Inc. announced plans to launch generic versions of its hepatitis C drugs in the United States, at a time when regulators are looking to lower healthcare costs. The drugmaker’s generic version of drugs such as harvoni and epclusa, which raked in combined sales of $831 million in the quarter ended

Rx makers should work to reframe pricing debate

Rx makers should work to reframe pricing debate

The 2016 presidential race is already well under way. Despite thousands of speeches, interviews and, on the Republican side, two debates, there is a lot about the candidates’ thinking that needs to be clarified. One thing, however, is certain —  health care will be a prominent issue as the process of choosing Barack Obama’s successor

CVS strikes deal with Gilead

WOONSOCKET, R.I. — CVS Health and Gilead Sciences have reached a deal to make Gilead’s hepatitis C drugs, Harvoni and Sovaldi, the exclusive option for patients on its commercial drug list, as well as for those it manages on health care exchanges, Medicare Part D and Medicaid. The move partly counteracts a recent decision by